1. Home
  2. |Insights
  3. |FDLI - Enforcement and Litigation Conference: Enforcement in a Post-Wyeth, New Administration World

FDLI - Enforcement and Litigation Conference: Enforcement in a Post-Wyeth, New Administration World

Event | 10.13.09 - 10.14.09, 12:00 AM UTC - 12:00 AM UTC

FDA Commissioner Dr. Margaret Hamburg delivered a key policy speech at FDLI on August 6, 2009. She promised a more aggressive posture with respect to enforcement and provided insight into those areas where FDA would focus. The FDLI Enforcement Conference is the single best source for understanding where FDA and other enforcement officials are planning to focus. No other conference brings together more government officials to speak about enforcement, and this year, more than ever, you cannot afford to miss what they have to say.

Not only is there likely to be more FDA heat for industry with Commissioner Hamburg at the helm, there is sure to be a surge in whistleblower cases, major criminal investigations, and increasing state prosecutor attention to pharmaceutical and medical device manufacturers and distributors. So, if you think you know FDA enforcement, think again. The laws and the enforcers have changed.

Steven Niedelman is one of the speakers at this event.

For more information, please visit these areas: Product Risk Management

Insights

Event | 12.04.25

ACI 30th Annual Conference on Drug & Medical Device Litigation

Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures.